Methodist Journal

IN THIS ISSUE

Venous Interventions

Vol 14, Issue 3 (2018)


FEATURED GUEST EDITOR

ISSUE INTRO

It’s Time We Reassess Our Primitive Understanding of the Venous System

See More
RECOGNITIONS

Jean Bismuth Spearheads Issue on Venous Interventions

See More

REVIEW ARTICLES See More

Central Venous Pathologies: Treatments and Economic Impact

Venous Thrombosis and Post-Thrombotic Syndrome: From Novel Biomarkers to Biology

Mechanical Properties of Diseased Veins

Use of Computed Tomography and Magnetic Resonance Imaging in Central Venous Disease

Application of Intravascular Ultrasound in End-Stage Renal Patients with Central Venous Occlusive Disease

Intraoperative Imaging and Image Fusion for Venous Interventions

Endovascular Treatment for Venous Diseases: Where are the Venous Stents?

Endovascular Therapy for Central Venous Thrombosis

CASE REPORTS See More

Immune Checkpoint Inhibitor Related Cardiotoxicity

Tyrosine Kinase Inhibitor-Induced Acute Myocarditis, Myositis, and Cardiogenic Shock

Primary Nonbacterial Thrombotic Endocarditis Presenting with Bowel Infarction Secondary to Superior Mesenteric Artery Embolism

Persistent Left Superior Vena Cava with Absent Right Superior Vena Cava

MUSEUM OF HMH MULTIMODALITY IMAGING CENTER See More

Incision and Drainage of a Forgotten Vascular Graft

CLINICAL PERSPECTIVES See More

EXCERPTA

Telemedicine Shakes Up the ICU Experience

POINTS TO REMEMBER

Venous Thrombosis in Nephrotic Syndrome

EXCERPTA

Heartsick: Medical and Ethical Challenges of Infective Endocarditis in the Opioid Epidemic

EXCERPTA

Redefining “Worth It” for CTO PCI

EDITORIALS

Letter to the Editor

Vol 14, Issue 1 (2018)

Article Full Text

RECOGNITIONS

Guest Editor Neal Kleiman Leads Issue on the Current Status of Stents

Jump to:
Article Citation:

Guest Editor Neal Kleiman Leads Issue on the Current Status of Stents. Methodist DeBakey Cardiovasc J. 2018;14(1):4.

doi: 10.14797/mdcj-14-1-4

Neal S. Kleiman, M.D.

The editors of the Methodist DeBakey Cardiovascular Journal extend their deepest gratitude to Neal S. Kleiman, M.D., for his leadership in this special issue on the current status of stents. Dr. Kleiman is the medical director of the cardiac catheterization laboratories and program director of the Interventional Cardiology Fellowship at the Houston Methodist DeBakey Heart & Vascular Center at Houston Methodist Hospital. He is also a professor of cardiology for the Houston Methodist Institute for Academic Medicine and Weill Cornell Medical College.

Dr. Kleiman launched his career in Houston shortly after graduating from Columbia University College of Physicians and Surgeons, completing his internship, residency, and cardiology fellowship at Baylor College of Medicine. He joined the Houston Methodist faculty in 2005.

A prolific researcher, Dr. Kleiman has been the principal or collaborating investigator in more than 100 studies and multicenter trials examining arterial thrombosis, clotting, and percutaneous interventions. His laboratory is nationally recognized as a select site for platelet research where Dr. Kleiman leads studies on the effects of antiplatelet therapy in angioplasty procedures for coronary artery disease. Moreover, Dr. Kleiman has published more than 400 peer-reviewed manuscripts, book chapters, and abstracts in publications including the Journal of the American College of Cardiology, Annals of Thoracic Surgery, Circulation, and the European Heart Journal. He is a valued member of our editorial board, along with those of the Journal of Interventional Cardiology, Circulation, the American Heart Journal, and the Journal of Thrombosis and Thrombolysis.

Dr. Kleiman is active in several professional organizations, including the American Heart Association Council on Clinical Cardiology and Council on Thrombosis, and he is a fellow of the American College of Cardiology and the Society for Cardiovascular Angiography and Interventions.

Add Comments

Please login to dialogue with author.

Comments